Global

Healthcare Experts

Paul Clevelan

Chairman
Healthcare
Bioagri Laboratories
United States of America

Biography

 Effective December 9, 2015, Mr. Cleveland will serve as Chief Executive Officer and member of the board of directors of Avalanche Biotechnologies, Inc. Previously, he was President and Chief Executive Officer of Celladon Corporation, and prior to that, was Celladon’s President and Chief Financial Officer. Mr. Cleveland also currently serves as a member of the board of directors and as Chairman of the Audit Committee of Sangamo Biosciences, Inc. Prior to Celladon, he served as Executive Vice President, Corporate Strategy and Chief Financial Officer at Aragon Pharmaceuticals before its acquisition by Johnson & Johnson. Prior to Aragon, he was General Partner and Chief Operating Office at Mohr Davidow Ventures and Executive Vice President, Corporate Development and Chief Financial Officer for Affymax. He previously was an investment banker at J.P. Morgan Chase and Co. and a predecessor firm, Hambrecht & Quist, and a corporate lawyer at Cooley LLP, Sidley Austin LLP, and Davis Polk & Wardwell LLP. Mr. Cleveland holds a bachelor’s degree from Washington University in St. Louis and a J.D. from Northwestern University School of Law.

Research Interest

 Effective December 9, 2015, Mr. Cleveland will serve as Chief Executive Officer and member of the board of directors of Avalanche Biotechnologies, Inc. Previously, he was President and Chief Executive Officer of Celladon Corporation, and prior to that, was Celladon’s President and Chief Financial Officer. Mr. Cleveland also currently serves as a member of the board of directors and as Chairman of the Audit Committee of Sangamo Biosciences, Inc. Prior to Celladon, he served as Executive Vice President, Corporate Strategy and Chief Financial Officer at Aragon Pharmaceuticals before its acquisition by Johnson & Johnson. Prior to Aragon, he was General Partner and Chief Operating Office at Mohr Davidow Ventures and Executive Vice President, Corporate Development and Chief Financial Officer for Affymax. He previously was an investment banker at J.P. Morgan Chase and Co. and a predecessor firm, Hambrecht & Quist, and a corporate lawyer at Cooley LLP, Sidley Austin LLP, and Davis Polk & Wardwell LLP. Mr. Cleveland holds a bachelor’s degree from Washington University in St. Louis and a J.D. from Northwestern University School of Law.

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America